ONVO Key Stats
- 3D Printing Hype May Be 'Overdone' - Analyst (DDD) (SSYS) (XONE) Street Insider 8:02 AM
- 5 Stocks Under $10 Moving Higher The Street Dec 6
- ORGANOVO HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement Dec 5
- 3 Stocks to Get on Your Watchlist Fool Dec 4
- Today's Market: 3-D Stocks Rallying On Bullish Sentiment Seeking Alpha Dec 4
- 3 Things for Organovo Investors to Watch in 2014 Fool Dec 4
- 3 Disruptive Medical Innovations You Can Invest In Fool Dec 3
- NYSE, OTC and Nasdaq Companies Webcast to Online Investors: December 5th at RetailInvestorConferences.com PR Newswire Dec 3
- Organovo Holdings, Inc. to Webcast, Live, at RetailInvestorConferences.com December 5th noodls Dec 2
- Organovo to Present at the 24th Annual Oppenheimer Healthcare Conference noodls Dec 2
ONVO Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Organovo Holdings is up 369.8% over the last year vs S&P 500 Total Return up 30.68%, BioTelemetry up 237.4%, and Pfizer up 27.47%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for ONVO
Pro Report PDF for ONVO
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download ONVO Pro Report PDF
Pro Strategies Featuring ONVO
Did Organovo Holdings make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Organovo Holdings Inc., is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.